Blumeyer A, Tosti A, Messenger A, Reygagne P, del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG J der Dtsch Dermatologischen Gesellschaft. 2011;9:1–57. https://doi.org/10.1111/j.1610-0379.2011.07802.x.
Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708–28. https://doi.org/10.1111/j.1749-6632.1951.tb31971.x.
Ramos PM, Miot HA. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90(4):529–43.
Gentile G. Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells. 2019;8(5):466.
Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4(22):1–11.
Urysiak-Czubatka I, Kmieć ML, Broniarczyk-Dyła G. Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia. Postep dermatologii i Alergol. 2014;31(4):207–15.
Otberg N, Finner AM, Shapiro J. Androgenetic Alopecia. Endocrinol Metab Clin North Am. 2007;36(2):379–98.
Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol. 2001;116(3):452–5.
Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5α-reductase genes. J Invest Dermatol. 1998;110(6):849–53.
Mirmirani P. Hormones and clocks: Do they disrupt the locks? Fluctuating estrogen levels during menopausal transition may influence clock genes and trigger chronic telogen effluvium. Dermatol Online J. 2016;22(5). https://pubmed.ncbi.nlm.nih.gov/27617515/
Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: Androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol. 2019;80(6):1497–506. https://doi.org/10.1016/j.jaad.2018.08.062.
Rompolas P, Greco V. Stem cell dynamics in the hair follicle niche. Semin Cell Dev Biol. 2014;25–26:34–42.
Plikus MV, Mayer JA, de la Cruz D, Baker RE, Maini PK, Maxson R, et al. Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature. 2008;451(7176):340–4.
Wang AB, Jain P, Tumbar T. The hair follicle stem cell niche: the bulge and its environment. Tissue-Specific Stem Cell Niche. 2015. https://doi.org/10.1007/978-3-319-21705-5_1.
Tsuboi R, Niiyama S, Irisawa R, Harada K, Nakazawa Y, Kishimoto J. Autologous cell–based therapy for male and female pattern hair loss using dermal sheath cup cells: a randomized placebo-controlled double-blinded dose-finding clinical study. J Am Acad Dermatol. 2020;83(1):109–16.
Kwack MH, Sung YK, Chung EJ, Im SU, Ahn JS, Kim MK, et al. Dihydrotestosterone-inducible Dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular keratinocytes. J Invest Dermatol. 2008;128(2):262–9.
Kitagawa T, Matsuda K-I, Inui S, Takenaka H, Katoh N, Itami S, et al. Keratinocyte growth inhibition through the modification of Wnt signaling by androgen in balding dermal papilla cells. J Clin Endocrinol Metab. 2009;94(4):1288–94.
Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2006;116(1):249–60.
Mohammadi P, Youssef KK, Abbasalizadeh S, Baharvand H, Aghdami N. Human hair reconstruction: close, but yet so far. Stem Cells Dev. 2016;25(23):1767–79.
Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG, et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int. 2014;2014:760709.
Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol. 1992;127(3):239–46.
Houschyar KS, Borrelli MR, Tapking C, Popp D, Puladi B, Ooms M, et al. Molecular mechanisms of hair growth and regeneration: current understanding and novel paradigms. Dermatology. 2020;236(4):271–80.
Andy G, John M, Mirna S, Rachita D, Michael K, Maja K, et al. Controversies in the treatment of androgenetic alopecia: The history of finasteride. Dermatol Ther. 2019;32(2):e12647.
Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, et al. Re: Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men [5]. J Urol. 2000;164(4):1319–20.
Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version. J Eur Acad Dermatology Venereol. 2018;32(1):11–22.
Kelly Y, Blanco A, Tosti A. Androgenetic Alopecia: An Update of Treatment Options. Vol. 76, Drugs. Springer International Publishing; 2016. p. 1349–64
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia. 2023: https://www.clinicaltrials.gov/search?term=NCT03004469
Ahmed OAA, Rizq WY. Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach. Drug Des Devel Ther. 2018;12:2259–65.
Piraccini BM, Blume-Peytavi U, Scarci F, Jansat JM, Falqu M, Otero R, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. 2021; https://doi.org/10.1111/jdv.17738
Gupta AK, Talukder M. Topical finasteride for male and female pattern hair loss: is it a safe and effective alternative? J Cosmet Dermatol. 2022;21(5):1841–8. https://doi.org/10.1111/jocd.14895.
Inui S, Itami S. Reversal of androgenetic alopecia by topical ketoconzole: Relevance of anti-androgenic activity. J Dermatol Sci. 2007;45(1):66–8.
Hugo Perez BS. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. Med Hypotheses. 2004;62(1):112–5.
Sonino N, Scaroni C, Biason A, Boscaro M, Mantero F. Low-dose ketoconazole treatment in hirsute women. J Endocrinol Investig Off J Ital Soc Endocrinol. 1990;13(1):35–40.
Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489–98.
Mahe YF, et al. Androgenetic alopecia and microinflammation. Int J Dermatol. 2000;39:576–84.
Orasan MS, Roman II, Coneac A, Muresan A, Orasan RI. Hair loss and regeneration performed on animal models. Med Pharm Reports. 2015;89(3):327–34.
Panchaprateep R, Lueangarun S. Efficacy and safety of oral minoxidil 5 mg once daily in the treatment of male patients with androgenetic alopecia: an open-label and global photographic assessment. Dermatol Ther (Heidelb). 2020;10(6):1345–57.
Jha A, Sonthalia S, Zeeshan MD. Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia. J Am Acad Dermatology. 2020;83(5):1491–3.
Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104–9.
Sinclair R, Perera E. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. F1000Research 2017 61650. 2017;6:1650.: https://f1000research.com/articles/6-1650
Sinclair R, Trindade de Carvalho L, Ferial Ismail F, Meah N. Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case-series of 64 patients. J Eur Acad Dermatology Venereol. 2020;34(12):795–6.
Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol. 1990;95(5):553–7.
Maekawa M, Ohnishi T, Balan S, Hisano Y, Nozaki Y, Ohba H, et al. Thiosulfate promotes hair growth in mouse model. Biosci Biotechnol Biochem. 2019;83(1):114–22.
Ramos PM, Goren A, Sinclair R, Miot HA. Oral minoxidil bio-activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss. J Eur Acad Dermatology Venereol. 2020;34(1):e40-1.
Lee HJ, Oh DW, Na MJ, Kim DW, Yuk DY, Choi HC, et al. Preparation and in vivo evaluation of lecithin-based microparticles for topical delivery of minoxidil. Arch Pharm Res. 2017;40(8):943–51.
Carvalho R de M, Santos LDN, Ramos PM, Machado CJ, Acioly P, Frattini SC, et al. Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know. J Cosmet Dermatol. 2022;21(10):4171–5
Ocampo-Garza J, Griggs J, Tosti A. New drugs under investigation for the treatment of alopecias. Expert Opin Investig Drugs. 2019;28(3):275–84.
NCT01904721. A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA). 2016.: https://www.clinicaltrials.gov/study/NCT01904721?term=NCT01904721&rank=1&limit=10
NCT01325337. Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia. 2014: https://www.clinicaltrials.gov/study/NCT01325337?term=NCT01325337&rank=1
NCT0132535. Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss. 2014: https://www.clinicaltrials.gov/study/NCT01325350?term=NCT01325350&rank=1
Topical Bimatoprost Effect on Androgen Dependent Hair Follicles. [cited 2023 Jul 31].: https://www.clinicaltrials.gov/study/NCT02170662?term=NCT02170662&rank=1
Blume-Peytavi U, Hillmann K, Garcia Bartels N. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. https://pubmed.ncbi.nlm.nih.gov/21875758
Nieves A, Garza LA. Does prostaglandin D2 hold the cure to male pattern baldness? Exp Dermatol. 2014 Apr [cited 2019 Jul 29];23(4):224–7.: http://www.ncbi.nlm.nih.gov/pubmed/24521203
NCT02781311. A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males. clinicaltrials.gov. 2019: https://www.clinicaltrials.gov/study/NCT02781311?term=NCT02781311&rank=1
Mohamed S. Zaky MD1 | Hassan Abo Khodeir MD1 | Hebat-Allah Ahmed MD1 |, Mohamed L. Elsaie MD. Therapeutic implications of topical cetirizine 1% in treatment of male androgenetic alopecia: A case-controlled study. 2020: https://onlinelibrary.wiley.com/doi/pdfdirect/https://doi.org/10.1111/jocd.13940
Bassiouny EA, Solwan, El-Samanoudy I, Abbassi MM, Nada HR, Samar , et al. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study. 2023;315:1293–304.: https://doi.org/10.1007/s00403-022-02512-2
Lee S-H, Yoon J, Shin SH, Zahoor M, Kim HJ, Park PJ, et al. Valproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cells. 2012: https://pubmed.ncbi.nlm.nih.gov/22506014/
Harel S, Higgins CA, Cerise JE, Dai Z, Chen JC, Clynes R, et al. Pharmacologic inhibition of JAK-STAT signaling promotes hair growth. Sci Adv. 2015;1(9).: https://pubmed.ncbi.nlm.nih.gov/26601320/
A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) – Full Text View – ClinicalTrials.gov. [cited 2022 Sep 26].: https://clinicaltrials.gov/ct2/show/NCT02275351
A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing – Full Text View – ClinicalTrials.gov. [cited 2022 Sep 26].: https://clinicaltrials.gov/ct2/show/NCT02503137?cond=NCT02503137&draw=2&rank=1
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27].: https://clinicaltrials.gov/ct2/show/NCT03495817?term=NCT03495817&draw=2&rank=1
“iRestore” Light Therapy Apparatus – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27].: https://clinicaltrials.gov/ct2/show/NCT03331003?term=CELL+THERAPY&cond=aga&draw=2&rank=25
Wu Y-F, Wang S-H, Wu P-S, Fan SM-Y, Chiu H-Y, Tsai T-H, et al. Enhancing hair follicle regeneration by nonablative fractional laser: assessment of irradiation parameters and tissue response. Lasers Surg Med. 2015;47(4):331–41
Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR. Low-level laser (Light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med. 2014;46:144–51.
Darwin E, Heyes A, Hirt PA, Wikramanayake TC, Jimenez JJ. Low-level laser therapy for the treatment of androgenic alopecia: a review. Lasers Med Sci. 2018;33(2):425–34.
Pillai J, Mysore V. Role of low-level light therapy (LLLT) in androgenetic alopecia. Vol. 14, Journal of Cutaneous and Aesthetic Surgery. 2021. p. 385. https://pubmed.ncbi.nlm.nih.gov/35283601
Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013;39(8):1177–83.
Lanzafame RJ, Blanche RR, Bodian AB, Chiacchierini RP, Fernandez-Obregon A, Kazmirek ER. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers Surg Med. 2013;45(8):487–95.
Lee GY, Lee SJ, Kim WS. The effect of a 1550 nm fractional erbium-glass laser in female pattern hair loss. J Eur Acad Dermatol Venereol. 2011;25(12):1450–4.
Meephansan J, Ungpraphakorn N, Ponnikorn S, Suchonwanit P, Poovorawan Y. Efficacy of 1,550-nm erbium-glass fractional laser treatment and its effect on the expression of insulin-like growth factor 1 and Wnt/β-catenin in androgenetic alopecia. Dermatol Surg. 2018;44(10):1295–303.
Alhattab MK, AL Abdullah MJ, Al-Janabi MH, Aljanaby WA, Alwakeel HA. The effect of 1540-nm fractional erbium-glass laser in the treatment of androgenic alopecia. J Cosmet Dermatol. 2020;19(4):878–83.
Suchonwanit P, Rojhirunsakool S, Khunkhet S. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. Lasers Med Sci. 2019;34(9):1857–64.
Haddad N, Arruda S, Sadick N. Evaluating the efficacy of platelet rich plasma and 1550 nm fractional laser in combination and alone for the management of androgenetic alopecia. J Drugs Dermatol. 2022;21(11):1166–9.
Leavitt M, Perez-Meza D, Rao NA, Barusco M, Kaufman KD, Ziering C. Effects of finasteride (1 mg) on hair transplant. Dermatol Surg. 2005;31(10):1268–76.
Cole JP. An analysis of follicular punches, mechanics, and dynamics in follicular unit extraction. Facial Plast Surg Clin North Am. 2013;21(3):437–47.
Rogers NE, Callender VD. Advances and challenges in hair restoration of curly Afrocentric hair. Dermatol Clin. 2014;32(2):163–71.
Rose P. The latest innovations in hair transplantation. Facial Plast Surg. 2011;27(04):366–77.
Caroli S, Pathomvanich D, Amonpattana K, Kumar A. Current status of hair restoration surgery. Int Surg. 2011;96(4):345–51.
Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol Online J. 2016;7(4):244.
Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013;5(1):6.
Kumar M, Inamadar A, Palit A. A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia. J Cutan Aesthet Surg. 2018;11(4):211–6.
Bao L, Fang H, Zheng LLY. Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway. 2020. p. 483–93
Yu C-Q, Zhang H, Guo M-E, Li X-K, Chen H-D, Li Y-H, et al. Combination therapy with topical minoxidil and nano-microneedle-assisted fibroblast growth factor for male androgenetic alopecia: a randomized controlled trial in Chinese patients. 2021. http://links.lww.com/CM9/A373
Melo DF, de Mattos Barreto T, Plata GT, Araujo LR, Tortelly VD. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia. J Cosmet Dermatol. 2019; 2019; https://pubmed.ncbi.nlm.nih.gov/ 31066492/
Melo DF, Saceda-Corralo D, Tosti A, Weffort F, Carla Jorge M, de Barros CC, et al. Frontal edema due to mesotherapy for androgenetic alopecia: a case series. Dermatol Ther. 2022;35(2):8–10.
Gajjar P, Mehta H, Barvaliya M, Sonagra B. Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: a randomized controlled trial. Int J Trichol. 2019;11(2):58–67.
Nassar A, Abdel-Aleem H, Samir M, Khattab FM. Efficacy of botulinum toxin A injection in the treatment of androgenic alopecia: a comparative controlled study. J Cosmet Dermatol. 2022;21(10):4261–8.
Jung BH, Song SH, Yoon SJ, Koo JH, Yoo KY. The effect of botulinum toxin on hair follicle cell regeneration under continuous stress conditions: a pilot animal study. Neurotox Res. 2022;40(1):103–10. https://doi.org/10.1007/s12640-021-00453-8.
Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z. Effectiveness and safety of botulinum toxin type a in the treatment of androgenetic alopecia. Biomed Res Int. 2020;2020.
Use of Botulinum Toxin in the Treatment of Androgenic Alopecia. 2022 [cited 2023 Aug 2]. https://www.clinicaltrials.gov/study/NCT05456087?term=botulinum toxin&cond=aga&rank=2
Treatment of Male Pattern Baldness With Botulinum Toxin. 2009. https://www.clinicaltrials.gov/study/NCT00965640?term=botulinum toxin&cond=aga&rank=1
Zhu H-L, Gao Y-H, Yang J-Q, Li J-B, Gao J. Serenoa repens extracts promote hair regeneration and repair of hair loss mouse models by activating TGF-β and mitochondrial signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(12):4000–8.
Murata K, Takeshita F, Samukawa K, Tani T, Matsuda H. Effects of Ginseng Rhizome and Ginsenoside Ro on Testosterone 5α-Reductase and Hair Re-growth in Testosterone-treated Mice. 2011; https://pubmed.ncbi.nlm.nih.gov/21538628
Wall D, Meah N, Fagan N, York K, Sinclair R. Advances in hair growth. Fac Rev. 2022;11. https://pubmed.ncbi.nlm.nih.gov/35156098/
Kwon OS, Han JH, Yoo HG, Chung JH, Cho KH, Eun HC, et al. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine. 2007;14(7–8):551–5.
Srivilai J, Rabgay K, Khorana N, Waranuch N, Nuengchamnong N, Wisuitiprot W, et al. Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors. Med Chem Res. 2017. https://doi.org/10.1007/s00044-017-1869-y.
Hou IC, Oi Y, Fujita H, Yano Y, Fukami H, Yoshikawa M. A hair growth-promoting effect of Chinese black tea extract in mice. Biosci Biotechnol Biochem. 2013;77(7):1606–7.
Uri Shon MD, Myung Hwa Kim MD, Dong Yoon Lee MD SHKP y BCPM. The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism. J Am Acad Dermatol. 2020;83(6):1838–9
Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z. Effectiveness and safety of botulinum toxin type a in the treatment of androgenetic alopecia. 2020: https://doi.org/10.1155/2020/1501893
Zhang L, Yu Q, Wang Y, Ma Y, Shi Y, Li X. A small dose of botulinum toxin A is effective for treating androgenetic alopecia in Chinese patients. Dermatol Ther. 2019;32(4).: https://pubmed.ncbi.nlm.nih.gov/30566260/
Singh S, Neema S, Vasudevan B. A pilot study to evaluate effectiveness of botulinum toxin in treatment of androgenetic alopecia in males. J Cutan Aesthet Surg. 2017;10(3):163–7.
Freund BJ, Schwartz M. Treatment of male pattern baldness with botulinum toxin: A pilot study. Plast Reconstr Surg. 2010 Nov [cited 2024 May 27];126(5).: https://journals.lww.com/plasreconsurg/fulltext/2010/11000/treatment_of_male_pattern_baldness_with_botulinum.79.aspx
English Jr Sophia Ruiz RS. Systematic Review and Meta-Analysis Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review. 2021: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928186/
Khalilov R, Bakishzade A, Nasibova A. Future prospects of biomaterials in nanomedicine. Adv Biol Earth Sci. 2024;9:5–10.
Huseynov E, Khalilov R, Mohamed AJ. Novel nanomaterials for hepatobiliary diseases treatment and future perspectives. Adv Biol Earth Sci. 2024;9:81–91.
Salahshour P, Abdolmaleki S, Monemizadeh S, Gholizadeh S, Khaksar S. Nanobiomaterials/bioinks based scaffolds in 3d bioprinting for tissue engineering and artificial human organs. Adv Biol Earth Sci. 2024;9:97–104.
Saghir Z, Shaikh A, Ahmed B, Patel A, Patil SG, Raheem A, et al. Nanotechnology-based strategies for hair follicle regeneration in androgenetic alopecia. Mater Proc. 2023;14:57.
Roque LV, Dias IS, Cruz N, Rebelo A, Roberto A, Rijo P, et al. Design of finasteride-loaded nanoparticles for potential treatment of alopecia. Skin Pharmacol Physiol. 2017;30(4):197–204.
Kim JH, Na J, Bak DH, Lee BC, Lee E, Choi MJ, et al. Development of finasteride polymer microspheres for systemic application in androgenic alopecia. Int J Mol Med. 2019;43(6):2409–19.
Xiao Q, Lu Y, Yao W, Gong CC, Jia C, Gao J, et al. Molybdenum nanoparticles as a potential topical medication for alopecia treatment through antioxidant pathways that differ from minoxidil. J Trace Elem Med Biol. 2024;82. https://pubmed.ncbi.nlm.nih.gov/38150949/
Fernández-García R, Lalatsa A, Statts L, Bolás-Fernández F, Ballesteros MP, Serrano DR. Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale. Int J Pharm. 2020;573.: https://pubmed.ncbi.nlm.nih.gov/31678520/
Makky AMA, El-leithy E, Hussein DG, Khattab A. A full factorial design to optimize aminexil nano lipid formulation to improve skin permeation and efficacy against alopecia. AAPS PharmSciTech. 2023;24(1):1–19.
Lee HJ, Kwon HK, Kim HS, Kim M Il, Park HJ. Hair growth promoting effect of 4HGF encapsulated with PGA nanoparticles (PGA-4HGF) by β-catenin activation and its related cell cycle molecules. Int J Mol Sci. 2019;20(14). https://www.researchgate.net/publication/334461649_Hair_Growth_Promoting_Effect_of_4HGF_Encapsulated_with_PGA_Nanoparticles_PGA-4HGF_by_b-Catenin_Activation_and_Its_Related_Cell_Cycle_Molecules
Monti D, Tampucci S, Burgalassi S, Chetoni P, Lenzi C, Pirone A, et al. Topical formulations containing finasteride Part I: In vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat. J Pharm Sci. 2014;103(8):2307–14.
Yang Y, Wang P, Gong Y, Yu Z, Gan Y, Li P, et al. Curcumin-zinc framework encapsulated microneedle patch for promoting hair growth. Theranostics. 2023;13(11):3675–88.
Hydraderm for Androgenic Alopecia – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27].: https://clinicaltrials.gov/ct2/show/NCT05426629?term=CELL+THERAPY&cond=aga&draw=2&rank=24
Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality – Full Text View – ClinicalTrials.gov. [cited 2024 May 31].: https://classic.clinicaltrials.gov/ct2/show/NCT06112782?term=hydradermabrasion&cond=androgenetic+alopecia&draw=2&rank=2
Utomo DN, Hernugrahanto KD, Edward M, Widhiyanto L, Mahyudin F. Combination of bone marrow aspirate, cancellous bone allograft, and platelet-rich plasma as an alternative solution to critical-sized diaphyseal bone defect: A case series. Int J Surg Case Rep. 2019;58:178–85.
Kunze KN, Pakanati JJ, Vadhera AS, Polce EM, Williams BT, Parvaresh KC, et al. The efficacy of platelet-rich plasma for ligament injuries a systematic review of basic science literature with protocol quality assessment. 2019. http://www.sagepub.com/journals-permissions.
Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surgery, Sport Traumatol Arthrosc. 2010;18(4):472–9.
Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A. PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Cartilage. 2021;13(1):364S-375S.
Hausauer AK, Jones DH. Evaluating the efficacy of different platelet-rich plasma regimens for management of androgenetic alopecia: a single-center, blinded, randomized clinical trial. Dermatol Surg. 2018;44(9):1191–200.
Gupta AK, Cole J, Deutsch DP, Everts PA, Niedbalski RP, Panchaprateep R, et al. Platelet-rich plasma as a treatment for androgenetic alopecia. Dermatologic Surg. 2019;1.: http://insights.ovid.com/crossref?an=00042728-900000000-98404
Gentile P, Scioli MG, Bielli A, De Angelis B, De Sio C, De Fazio D, et al. Platelet-rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair re-growth in androgenetic alopecia. biomolecular pathway analysis and clinical evaluation. Biomedicines. 2019;7(2):27
Gupta AK, Versteeg SG, Rapaport J, Hausauer AK, Shear NH, Piguet V. The efficacy of platelet-rich plasma in the field of hair restoration and facial aesthetics—a systematic review and meta-analysis. J Cutan Med Surg. 2019;23(2):185–203.
Khatu SS, More YE, Gokhale NR, Chavhan DC, Bendsure N. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. J Cutan Aesthet Surg. 2014;7(2):107–10.
Shetty VH, Goel S. Dermoscopic pre‐ and posttreatment evaluation in patients with androgenetic alopecia on platelet‐rich plasma—A prospective study. J Cosmet Dermatol. 2018;jocd.12845.
Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R. A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia. Int J Trichology. 2019;11(2):68–79.
Bayat M, Yazdanpanah MJ, Hamidi Alamdari D, Banihashemi M, Salehi M. The effect of platelet-rich plasma injection in the treatment of androgenetic alopecia. J Cosmet Dermatol. 2019. https://doi.org/10.1111/jocd.12907.
Pakhomova EE, Smirnova IO. Comparative evaluation of the clinical efficacy of prp-therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia. Int J Mol Sci. 2020;21(18):1–16.
Qu Q, Zhou Y, Shi P, Du L, Fan Z, Wang J, et al. Platelet-rich plasma for androgenic alopecia: a randomized, placebo-controlled, double-blind study and combined mice model experiment. J Cosmet Dermatol. 2021;20(10):3227–35.
Bruce AJ, Pincelli TP, Heckman MG, Desmond CM, Arthurs JR, Diehl NN, et al. A randomized, controlled pilot trial comparing platelet-rich plasma to topical minoxidil foam for treatment of androgenic alopecia in women. Dermatol Surg. 2020;46(6):826–32.
Dubin DP, Lin MJ, Leight HM, Farberg AS, Torbeck RL, Burton WB, et al. The effect of platelet-rich plasma on female androgenetic alopecia: a randomized controlled trial. J Am Acad Dermatol. 2020;83(5):1294–7.
Pavlovic V, Ciric M, Jovanovic V, Trandafilovic M, Stojanovic P. Platelet-rich fibrin: Basics of biological actions and protocol modifications. Open Med (Warsaw, Poland). 2021;16(1):446–54.
Choukroun J, Ghanaati S. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg. 2018;44:87–95.
Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? 2017; https://pubmed.ncbi.nlm.nih.gov/28154995/
Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016;20(9):2353–60.
Egierska D, Perszke M, Mazur M, Duś-Ilnicka I. Platelet-rich plasma and platelet-rich fibrin in oral surgery: a narrative review. Dent Med Probl. 2023;60(1):177–86.
Celikten M, Sahin H, Senturk GE, Bilsel K, Pulatkan A, Kapicioglu M, et al. The effect of platelet-rich fibrin, platelet-rich plasma, and concentrated growth factor in the repair of full thickness rotator cuff tears. J shoulder Elb Surg. 2024;33(5):e261-77.
Domingues RB, von Rautenfeld M, Kavalco CM, Caliari C, Dellagiustina C, da Fonseca LF, et al. The role of orthobiologics in chronic wound healing. Int Wound J. 2024;21(4):e14854
Omid Keyhan S, Hemmat S, Ali Badri A, Abdeshahzadeh A, Khiabani K. Use of platelet-rich fibrin and platelet-rich plasma in combination with fat graft: which is more effective during facial lipostructure? Oral Maxillofac Surg J Oral Maxillofac Surg. 2013;71:610–21. https://doi.org/10.1016/j.joms.2012.06.176.
Lu K, Han Q, Ma Z, Yan Q, Pei Y, Shi P, et al. Injectable platelet rich fibrin facilitates hair follicle regeneration by promoting human dermal papilla cell proliferation, migration, and trichogenic inductivity. Exp Cell Res. 2021;409(1):112888. https://doi.org/10.1016/j.yexcr.2021.112888.
Arora R, Shukla S. Injectable-platelet-rich fibrin-smart blood with stem cells for the treatment of alopecia: a report of three patients. Int J Trichol. 2019;11(3):128–31.
Bhoite KS, Chikhalkar SB, Mishra SN, Kharkar VD. Injectable platelet rich fibrin therapy for androgenetic alopecia: a series of 15 cases. Int J Res Dermatology. 2022;8(4):398–402.
Schiavone G, Paradisi A, Ricci F, Abeni D. Injectable platelet-, leukocyte-, and fibrin-rich plasma (Il-PRF) in the management of androgenetic alopecia. Dermatol Surg. 2018;44(9):1183–90.
Ali N, Diab F, Al-Shimaa ·, Ibrahim M, Aya ·, Abdallah M. Fluid platelet-rich fibrin (PRF) versus platelet-rich plasma (PRP) in the Treatment of Atrophic Acne Scars: A Comparative Study. 2023;315:1249–55. https://doi.org/10.1007/s00403-022-02511-3
Shashank B, Bhushan M. Injectable platelet-rich fibrin (prf): the newest biomaterial and its use in various dermatological conditions in our practice: a case series. J Cosmet Dermatol. 2021;20(5):1421–6.
Shimizu Y, Ntege EH, Sunami H, Inoue Y. Regenerative medicine strategies for hair growth and regeneration: a narrative review of literature. Regen Ther. 2022;21:527–39. https://doi.org/10.1016/j.reth.2022.10.005.
Nepal S, Venkataram A, Mysore V. The role of adipose tissue in hair regeneration: a potential tool for management? J Cutan Aesthet Surg. 2021;14(3):295–304.
Won CH, Yoo HG, Kwon OS, Sung MY, Kang YJ, Chung JH, et al. Hair growth promoting effects of adipose tissue-derived stem cells. Vol. 57, J. Dermatol Sci. 2010. p. 134–7. https://pubmed.ncbi.nlm.nih.gov/19963355/
Fukuoka H, Narita K, Suga H. Hair regeneration therapy: application of adipose-derived stem cells. Curr Stem Cell Res Ther. 2017;12(7). https://pubmed.ncbi.nlm.nih.gov/28530535/
Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyvk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17(4):331–40.
Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. 2003;5(1):1–14.
Schäffler A, Büchler C. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells. 2007;25(4):818–27.
Park B-S, Kim W-S, Choi J-S, Kim H-K, Won J-H, Ohkubo F, et al. Hair growth stimulated by conditioned medium of adipose-derived stem cells is enhanced by hypoxia: evidence of increased growth factor secretion. Biomed Res. 2010;31(1):27–34.
Fukuoka H, Suga H. Hair regeneration treatment using adipose-derived stem cell conditioned medium: follow-up with trichograms. Eplasty. 2015;15:e10.
Owczarczyk-Saczonek A, Wociór A, Placek W, Maksymowicz W, Wojtkiewicz J. The use of adipose-derived stem cells in selected skin diseases (vitiligo, alopecia, and nonhealing wounds). Stem Cells Int. 2017 Aug 21;2017:1–11. https://pubmed.ncbi.nlm.nih.gov/28904532/
Gentile P, Garcovich S. Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development. Cells. 2019;8(5). : http://www.ncbi.nlm.nih.gov/pubmed/31100937
Zhang P, Kling RE, Ravuri SK, Kokai LE, Rubin JP, Chai JK, et al. A review of adipocyte lineage cells and dermal papilla cells in hair follicle regeneration. J Tissue Eng. 2014;5. http://www.uk.sagepub.com/aboutus/openaccess.htm
Festa E, Fretz J, Berry R, Schmidt B, Rodeheffer M, Horowitz M, et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell. 2011;146(5):761–71.
He J, Duan H, Xiong Y, Zhang W, Zhou G, Cao Y, et al. Participation of CD34-enriched mouse adipose cells in hair morphogenesis. Mol Med Rep. 2013;7(4):1111–6.
Zografou A, Papadopoulos O, Tsigris C, Kavantzas N, Michalopoulos E, Chatzistamatiou T, et al. Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats. Ann Plast Surg. 2013;71(2):225–32.
Rokunohe A, Matsuzaki Y, Rokunohe D, Sakuraba Y, Fukui T, Nakano H, et al. Immunosuppressive effect of adipose-derived stromal cells on imiquimod-induced psoriasis in mice. J Dermatol Sci. 2016;82(1):50–3.
Lee YS, Sah SK, Lee JH, Seo KW, Kang KS, Kim TY. Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice. Biochem Biophys Reports. 2016;2017(9):281–8.
Wu J, Yang Q, Wu S, Yuan R, Zhao X, Li Y, et al. Adipose-derived stem cell exosomes promoted hair regeneration. Tissue Eng Regen Med. 2021;18(4):685–91. https://doi.org/10.1007/s13770-021-00347-y.
Zhou L, Wang H, Jing J, Yu L, Wu X, Lu Z. Regulation of hair follicle development by exosomes derived from dermal papilla cells. Biochem Biophys Res Commun. 2018;500(2):325–32. https://doi.org/10.1016/j.bbrc.2018.04.067.
Nilforoushzadeh MA, Aghdami N, Taghiabadi E. Human hair outer root sheath cells and platelet-lysis exosomes promote hair inductivity of dermal papilla cell. Tissue Eng Regen Med. https://doi.org/10.1007/s13770-020-00266-4
Rajendran RL, Gangadaran P, Seo CH, Kwack MH, Oh JM, Lee HW, et al. Macrophage-derived extracellular vesicle promotes hair growth. Cells. 2020;9(4):856.
Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lasser C, Segaliny AI, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano. 2019;13(6):6670–88.
Zhang B, Wang M, Gong A, Zhang X, Wu X, Zhu Y, et al. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells. 2015;33(7):2158–68.
Gentile P, Scioli MG, Bielli A, Orlandi A, Cervelli V. Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss. Stem cell Investig. 2017;4(7):58–58.
Zanzottera F, Lavezzari E, Trovato L, Icardi A, Graziano A. Adipose derived stem cells and growth factors applied on hair transplantation. follow-up of clinical outcome. J Cosmet Dermatological Sci Appl. 2014;4(4):268–74
Hamed Kadry M, Kheir WA El, Sayed Shalaby M El, El Shahid AR, Metwally HG. Autologous Adipose Derived Stem Cell versus Platelet Rich Plasma Injection in the Treatment of Androgentic Alopecia: Efficacy, Side Effects and Safety. J Clin Exp Dermatol Res. 2018;09(03). : https://www.omicsonline.org/open-access/autologous-adipose-derived-stem-cell-versus-platelet-rich-plasma-injection-in-the-treatment-of-androgentic-alopecia-efficacy-side-2155-9570-1000447-102382.html
Shin H, Ryu HH, Kwon O, Park BS, Jo SJ. Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: A retrospective case series study. Int J Dermatol. 2015;54(6):730–5.
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 31]. : https://clinicaltrials.gov/ct2/show/NCT05296863?term=NCT05296863&draw=2&rank=1
Tak YJ, Lee SY, Cho AR, Kim YS. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia. Stem Cells Transl Med. 2020;9(8):839–49.
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss – Full Text View – ClinicalTrials.gov. 2018. https://clinicaltrials.gov/ct2/show/NCT03662854?term=NCT03662854&draw=2&rank=1
Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia – Full Text View – ClinicalTrials.gov. 2018: https://clinicaltrials.gov/ct2/show/NCT03676400?term=NCT03676400&draw=2&rank=1
Adipose-derived SVF for Treatment of Alopecia – Full Text View – ClinicalTrials.gov. 2016. https://clinicaltrials.gov/ct2/show/NCT02626780?term=adipose&cond=AGA&draw=2&rank=4
Point-of-Care Adipose-derived Cells for Hair Growth – Full Text View – ClinicalTrials.gov. 2016. https://clinicaltrials.gov/ct2/show/NCT02729415?term=NCT02729415&draw=2&rank=1
Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT05129800?term=CELL+THERAPY&cond=aga&draw=2&rank=27
Fukuoka H, Suga H, Narita K, Watanabe R, Shintani S. The latest advance in hair regeneration therapy using proteins secreted by adipose-derived stem cells. Am J Cosmet Surg. 2015;29(4):273–82.
Gentile P, Scioli MG, Bielli A, Orlandi A, Cervelli V. Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss. Stem Cell Investig. 2017;4(7):58–58.
Mahmood S Choudhery APKEMU. Adipose tissue derived stem cell based hair restoration therapy for androgenetic alopecia – ClinicalTrials.gov. 2018. https://clinicaltrials.gov/ct2/show/NCT02865421?term=NCT02865421&draw=2&rank=1
Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT03388840?term=NCT03388840&draw=2&rank=1
Stevens HP, Donners S, De Bruijn J. Introducing platelet-rich stroma: platelet-rich plasma (PRP) and stromal vascular fraction (SVF) combined for the treatment of androgenetic alopecia. Aesthetic Surg J. 2018;38(8):811–22.
Kenneth Williams. AGA Biocellular Stem/Stromal Hair Regenerative Study – Full Text View – ClinicalTrials.gov. 2021. : https://clinicaltrials.gov/ct2/show/NCT02849470?term=NCT02849470&draw=2&rank=1
El-Khalawany M, Rageh MA, Elnokrashy I, Ibrahim SMA. Efficacy of autologous stromal vascular fraction injection in the treatment of androgenic alopecia. Arch Dermatol Res. 2022;0123456789. https://doi.org/10.1007/s00403-022-02501-5
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01669746?term=NCT01669746&draw=2&rank=1
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451151?term=CELL+THERAPY&cond=aga&draw=2&rank=17
A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451099?term=CELL+THERAPY&cond=aga&draw=2&rank=16
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451190?term=CELL+THERAPY&cond=aga&draw=2&rank=20
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451177?term=NCT01451177&draw=2&rank=1
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451125?term=CELL+THERAPY&cond=aga&draw=2&rank=15
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451138?term=CELL+THERAPY&cond=aga&draw=2&rank=18
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) – Full Text View – ClinicalTrials.gov. 2009. : https://clinicaltrials.gov/ct2/show/NCT01451112?term=NCT01451112&draw=2&rank=1
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451047?term=CELL+THERAPY&cond=aga&draw=2&rank=21
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451021?term=CELL+THERAPY&cond=aga&draw=2&rank=22
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 27]. : https://clinicaltrials.gov/ct2/show/NCT01451073?term=CELL+THERAPY&cond=aga&draw=2&rank=23
Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension to Treat AGA – Full Text View – ClinicalTrials.gov. [cited 2023 Mar 31]. : https://clinicaltrials.gov/ct2/show/NCT05659095?term=NCT05659095&draw=1&rank=1
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia – Full Text View – ClinicalTrials.gov. 2021. p. ClinicalTrials.gov. : https://clinicaltrials.gov/ct2/show/NCT01286649?term=CELL+THERAPY&cond=AGA&draw=2&rank=4
Elmaadawi IH, Mohamed BM, Ibrahim ZAS, Abdou SM, El Attar YA, Youssef A, et al. Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia. J Dermatolog Treat. 2018;29(5):431–40. https://pubmed.ncbi.nlm.nih.gov/27553744/
STYLE — A Trial of Cell Enriched Adipose For Androgenetic Alopecia. 2020. : https://www.clinicaltrials.gov/ct2/show/NCT02503852?term=kerastem&cond=androgenetic+alopecia&draw=2&rank=1
Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia | ClinicalTrials.gov. 2024. https://clinicaltrials.gov/study/NCT06239207?cond=androgenetic alopecia &term=Exosomes&rank=1
Llamas-Molina JM, Carrero-Castaño A, Ruiz-Villaverde R, Campos A. Tissue engineering and regeneration of the human hair follicle in androgenetic alopecia. Literature Review. 2022. https://doi.org/10.3390/life12010117.
Fisher JP, Mikos AG, Bronzino JD. Tissue engineering. Science (80- ). 1993. https://doi.org/10.1126/science.8493529
Castro AR, Logarinho E. Tissue engineering strategies for human hair follicle regeneration: How far from a hairy goal? 2019; https://pubmed.ncbi.nlm.nih.gov/31876379/
Lee V, Singh G, Trasatti JP, Bjornsson C, Xu X, Tran TN, et al. Design and fabrication of human skin by three-dimensional bioprinting. Tissue Eng Part C Methods. 2014;20(6):473.
Markstedt K, Mantas A, Tournier I, Martínez Ávila H, Hägg D, Gatenholm P. 3D bioprinting human chondrocytes with nanocellulose-alginate bioink for cartilage tissue engineering applications. Biomacromolecules. 2015;16(5):1489–96.
Cui H, Zhu W, Nowicki M, Zhou X, Khademhosseini A, Grace Zhang L, et al. Hierarchical fabrication of engineered vascularized bone biphasic constructs via dual 3D bioprinting: integrating regional bioactive factors into architectural design. Adv Healthc Mater. 2016;5(17):2174–81. https://doi.org/10.1002/adhm.201600505.
Laronda MM, Rutz AL, Xiao S, Whelan KA, Duncan FE, Roth EW, et al. A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice. Nat Commun. 2017;8(1):1–10.
Ma J, Qin C, Wu J, Zhuang H, Du L, Xu J, et al. 3D multicellular micropatterning biomaterials for hair regeneration and vascularization. Mater Horizons. 2023;10(9):3773–84.
Kang MS, Kwon M, Lee SH, Kim WH, Lee GW, Jo HJ, et al. 3D printing of skin equivalents with hair follicle structures and epidermal-papillary-dermal layers using gelatin/hyaluronic acid hydrogels. Chem – An Asian J. 2022;17(18):202200620. https://doi.org/10.1002/asia.202200620
Add Comment